Abstract: Pancreatic cancer organoids prepared by a method of the present invention sufficiently reflect the interaction between cancer cells and endothelial cells, that is, cross-talk with the vascular niche, and thus they can show the characteristics of cancer-initiating cells (CICs) present in the organism environment, compared to conventional cancer organoids. Accordingly, the clinical applicability and reliability of the screened drug may be further remarkably increased.

Abstract: Provided are a method for providing information about the diagnosis of a gallbladder polyp and a device for providing information about the diagnosis of a gallbladder polyp using same. The method for providing information about the diagnosis of a gallbladder polyp being implemented by a processor includes the steps of receiving an ultrasound medical image including a gallbladder part of a subject, determining the pathogenesis of a gallbladder polyp in the subject using a first assessment model configured to determine the pathogenesis of a gallbladder polyp on the basis of the ultrasound medical image, and determining characteristics of the gallbladder polyp on the basis of a second assessment model configured to classify characteristics of the gallbladder polyp when the gallbladder polyp is determined in the ultrasound medical image.

Abstract: The present invention relates to a method for diagnosis of bile duct cancer, using methionyl-tRNA synthetase (MRS) in bile duct cells of a latent patient.

Abstract: The present invention relates to a method for diagnosing pancreatic cancer using methionyl-tRNA synthetase (MRS). When used as a pancreatic cancer marker, MRS has a significantly higher level of diagnostic accuracy than conventional pancreatic cancer markers such as CEA; thus, analyzing the expression status of methionyl-tRNA synthetase (MRS) in pancreatic cells has the effect of clearly determining the presence or absence of pancreatic cancer, and said effect is likewise exhibited even in the cells that have been determined to be atypical cells by a general staining technique, and thus can be very useful in the diagnosis of pancreatic cancer.

Abstract: The present invention relates to a method for diagnosis of bile duct cancer, using methionyl-tRNA synthetase (MRS) in bile duct cells of a latent patient.